🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well niraparib and dostarlimab work in treati...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-10-17
Trial ID
NCT05870761
Treatments Being Tested
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested
ENGOT-OV42 / NSGO-AVATAR: This three-arm randomized trial is to demonstrate...
Status
Withdrawn
Location
NSGO
Start Date
2019-12
Trial ID
NCT03806049
Treatments Being Tested
Carcinosarcomas (CS) (malignant mixed Müllerian tumors) are highly aggressi...
Status
Recruiting
Location
ICO Paul Papin
Start Date
2020-07-15
Trial ID
NCT03651206
Treatments Being Tested
Ovarian cancer is a heterogeneous disease, characterized by complex molecul...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2018-10-11
Trial ID
NCT03602859
Treatments Being Tested
This is a multicenter, open-label, phase 2 study to evaluate the efficacy a...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-29
Trial ID
NCT03308942
Treatments Being Tested
This phase II trial studies the effect of niraparib and dostarlimab in trea...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-02-01
Trial ID
NCT04701307
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
The purpose of this study is to determine the best overall response of the ...
Status
Completed
Location
University of Cincinnati Medical Center
Start Date
2020-11-04
Trial ID
NCT04313504
Treatments Being Tested
Phase II, single arm trial, evaluating molecularly selected, immune-based c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-11
Trial ID
NCT04895046
Treatments Being Tested